Dr. Fredy Jesus Revilla, MD

Dr. Revilla practices at Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health.

Dr. Revilla's NPI, 1760418610, was assigned on June 23, 2006. Dr. Revilla holds South Carolina license 37641.

Dr. Revilla's primary practice is Prisma Health Greenville Memorial Hospital, at 701 Grove Road, Greenville, SC 29605 in Greenville County. The practice phone is (864) 455-7000.

Dr. Revilla's primary practice is Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health. Dr. Revilla is also affiliated with Prisma Health Hillcrest Hospital. The medical group on file is Prisma Health Medical Group. Dmand AI also links Dr. Revilla to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Revilla practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Revilla's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Revilla's licenses on file in 2 states: South Carolina and Ohio.

CMS data shows 23,965 Medicare services from Dr. Revilla across 7 procedure codes in 2024, for 229 Medicare patients. Medicare paid $155,187 for them. Every service was in an office.

CMS counts 229 Medicare patients who saw Dr. Revilla in 2024. The largest group is 75 to 84, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Revilla's median patient age at 73, with 45% women.

In 2024, Dr. Revilla wrote 1,788 Medicare Part D claims for 284 patients. 92% of them were for generic drugs. CMS names the drug for 1,610 of them, across 33 drugs with 11 or more claims each, at $789,137 in total drug cost. In 2023, CMS named 1,365 claims across 27 drugs.

Dr. Revilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Revilla as offering telehealth.

Dmand AI links 9 papers to Dr. Revilla, published from 2014 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Parkinson Disease, Pilot Projects and Yoga. Dr. Revilla has published most often in Evid Based Complement Alternat Med. Dr. Revilla's most frequent co-authors are Stuart H. Isaacson, MD, Kevin J. Klos, MD and Kathleen Valeska Woschkolup, MD.

Dmand AI links Dr. Revilla to 1 clinical trial. Conditions studied include Parkinson Disease and Parkinsonian Disorders. Open Payments lists research payments to Dr. Revilla that name 1 trial.

CMS Open Payments shows 571 general payments to Dr. Revilla from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $234,430. It also lists 7 research payments totaling $1,845 in 2019, naming 1 clinical trial.